COMPANY
Medicenna Therapeutics, Inc.
Funding and NIH signals
- SEC Form D raise Raised $253K (Form D filed Jul 6, 2026). SEC Form D 0001807983-26-000003 (Jul 6, 2026)
Evidence (1 event)
- Jul 6, 2026 · SEC Form D 0001807983-26-000003
Name of Issuer: Medicenna Therapeutics Corp.; CIK: 1807983; Address: Ontario, Canada; Submission type: D; Filing date: 2026-07-06; Industry Group: Biotechnology; Date of First Sale: 2026-05-28; Types of Securities Offered: Equity, Option/warrant, Security to be acquired, Other (Each Unit is comprised of 1 common share and 1/2 of 1 common share purchase warrant. Each Warrant entitles the holder thereof to purchase one additional Share at an exercise price of CDN$0.65 per Share for a period of 3 years following May 28, 2026.); Business combination transaction: false; Total Offering Amount: 2343400; Total Amount Sold: 253458; Federal exemptions: 06b
- Jul 6, 2026 · SEC Form D 0001807983-26-000003